EUVIMEDEUVIMED entdecken
Vergleichsstudie

Clinical and Radiologic Differences in Lung Involvement Between IgG4-Related Disease and Plasma Cell-Type Idiopathic Multicentric Castleman Disease

Jiamin Zhou iD, Xueqing Liu iD, Jian Li iD, Lu Zhang iD, Wen Zhang, Weihong Zhang iD

Lung · 2025

DOI: 10.1007/s00408-024-00782-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Lung, 2025. Verfasst von Jiamin Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No.1 Shuaifuyua…. Hauptthemen laut MEDLINE: Castleman Disease, Immunoglobulin G4-Related Disease, Tomography, X-Ray Computed, Immunoglobulin G. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National High-Level Hospital Clinical Research Funding, CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSES: Immunoglobulin G4-related disease (IgG4-RD) and plasma cell-type idiopathic multicentric Castleman disease (PC-iMCD) have many overlapping features. Their differential diagnosis is challenging and crucial for clinical management due to their different prognoses and treatments. However, reports that compare these conditions are scarce, especially for patients with lung involvement. In this study, we attempted to clarify the clinical and radiologic differences in lung involvement between IgG4-RD and PC-iMCD. METHODS: Patients with IgG4-RD or PC-iMCD who exhibited lung involvement were enrolled. Clinical and chest CT findings at baseline were compared. RESULTS: A total of 178 patients with IgG4-RD and 61 patients with PC-iMCD exhibited lung involvement. The IgG4-RD group consisted of older patients (P < 0.001) and had a higher male‒female ratio (P = 0.004). Patients with PC-iMCD were more inclined to present constitutional and respiratory symptoms, anemia, thrombocytosis and hypoalbuminemia (all P < 0.001). Although IgG4 levels were commonly elevated in both diseases, they were significantly greater in the IgG4-RD (median: 16,100 mg/L) than in the PC-iMCD (median: 3130 mg/L) (P < 0.001). Patients with IgG4-RD showed significantly lower levels of IgG, IgA, IgM (median: 21.59 g/L, 1.70 g/L, and 0.68 g/L, respectively) than in the PC-iMCD (median: 34.42 g/L, 4.85 g/L, and 2.11 g/L, respectively) (all P < 0.001). The levels of CRP, ESR and IL-6 were significantly greater in the PC-iMCD (median: 72.15 mg/L, 103 mm/h, and 18.30 pg/mL, respectively) than that in the IgG4-RD (median: 1.54 mg/L, 22 mm/h, and 2.85 pg/mL, respectively) (all P < 0.001). Although both nodular lesions and thickened bronchovascular bundles were common in these two diseases, PC-iMCD patients presented more extensive nodular lesions (P < 0.001), and IgG4-RD patients presented more diffuse thickened bronchovascular bundles (P < 0.001). Cysts were almost exclusively observed in PC-iMCD patients. CONCLUSIONS: Compared with IgG4-RD, PC-iMCD is a more aggressive condition, associated with more common symptoms and more severe inflammation. Radiologically, extensive nodular lesions or cysts suggest a diagnosis of PC-iMCD, whereas diffuse thickened bronchovascular bundles indicate a diagnosis of IgG4-RD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Castleman DiseaseImmunoglobulin G4-Related DiseaseTomography, X-Ray ComputedImmunoglobulin GHumansMaleFemaleMiddle AgedAdultDiagnosis, DifferentialAgedLungLung DiseasesRetrospective StudiesPlasma CellsInterleukin-6C-Reactive Protein

Stichwörter der Autor:innen

Idiopathic multicentric Castleman diseaseIgG4-related diseaseLung involvementLymphoplasmacyte proliferating disease

Substanzen

Immunoglobulin GInterleukin-6C-Reactive Protein

Autor:innen und Institutionen

  • Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
  • Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, 100730, No.1 Shuaifuyuan, Dongcheng District, Beijing, China.
  • Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, 100730, No.1 Shuaifuyuan, Dongcheng District, Beijing, China. pumczhanglu@126.com.
  • Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730, Chi…
  • Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China. zhangweihong@pumch.cn.

ORCID-Profile: Jiamin Zhou, Xueqing Liu, Jian Li, Lu Zhang, Weihong Zhang

Förderung

  • National High-Level Hospital Clinical Research Funding
  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation

Zitieren

APA

Zhou, J., Liu, X., Li, J., Zhang, L., Zhang, W., & Zhang, W. (2025). Clinical and Radiologic Differences in Lung Involvement Between IgG4-Related Disease and Plasma Cell-Type Idiopathic Multicentric Castleman Disease. Lung. https://doi.org/10.1007/s00408-024-00782-3

Vancouver

Zhou J, Liu X, Li J, Zhang L, Zhang W, Zhang W. Clinical and Radiologic Differences in Lung Involvement Between IgG4-Related Disease and Plasma Cell-Type Idiopathic Multicentric Castleman Disease. Lung. 2025. doi:10.1007/s00408-024-00782-3

BibTeX
@article{Zhou2025,
  author = {Zhou, Jiamin and Liu, Xueqing and Li, Jian and Zhang, Lu and Zhang, Wen and Zhang, Weihong},
  title = {Clinical and Radiologic Differences in Lung Involvement Between IgG4-Related Disease and Plasma Cell-Type Idiopathic Multicentric Castleman Disease},
  journal = {Lung},
  year = {2025},
  doi = {10.1007/s00408-024-00782-3}
}
Kostenlos starten →